Sign in

CIK 0000899923 · Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
870494517
Phone
801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
  1. 4 Grant or award Director acquired 49,796 shares (grant or award)
  2. 4 Grant or award Director acquired 24,148 shares (grant or award)
  3. 4 Grant or award Director acquired 49,796 shares (grant or award)
  4. 4 Grant or award Director acquired 49,796 shares (grant or award)
  5. 4 Grant or award Director acquired 49,796 shares (grant or award)
  6. 4 Grant or award Director acquired 49,796 shares (grant or award)
  7. 4 Grant or award Director acquired 49,796 shares (grant or award)
  8. 8-K Event Executive or director change · Shareholder vote results
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 4 Grant or award President and CEO acquired 1,498 shares (grant or award)
  11. SCHEDULE 13G Stake Statement of Beneficial Ownership
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. 4 Grant or award Chief Commerical Officer acquired 397,534 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. 4 Insider Changes in Ownership

Page 7 of 104 · 2,077 filings